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The Health Policy Commission (HPC), established in 2012, 
is charged with monitoring health care spending growth in 
Massachusetts and providing data-driven policy recommen-
dations regarding health care delivery and payment system 
reform. Consistent with this mandate, the HPC’s annual Cost 
Trends Report presents an overview of trends in health care 
spending and delivery in Massachusetts, evaluates progress 
in key areas, and makes recommendations for strategies to 
increase quality and efficiency in the Commonwealth.
Past cost trends reports have focused on four areas of 
opportunity: fostering a value-based market; promoting 
an efficient, high-quality healthcare delivery system; 
advancing aligned and effective financial incentives; 
and enhancing data and measurement for transparency 
and accountability.
The HPC continues to emphasize these opportunities in its 
analysis, recommendations, and strategic priorities.
This executive summary present a concise overview of the 
findings and recommendations detailed in this fifth annual 
report.
fInDInGs
TRENDS IN SPENDING 
• In 2016, Total Health Care Expenditures (THCE) in Mas-
sachusetts grew 2.8 percent per capita, lower than the 
3.6 percent health care cost growth benchmark set by 
the HPC. The average annual rate of growth in THCE in 
Massachusetts from 2012 to 2016 was 3.55 percent, slightly 
below the state’s benchmark.
 ○ The Massachusetts growth rate of 2.8 percent in 2016 
was below the national growth rate of 3.5 percent, 
continuing a seven year trend of total spending growth 
below the U.S. rate.
 ○ Growth in commercial health care spending contin-
ues to be below the national average. Cumulatively 
between 2012 and 2016, this lower growth rate 
amounts to commercial spending that has been $5.9 
billion lower over this time period than would have 
been the case if growth rates matched the national 
average.
• Per capita spending grew 3.2 percent among commercial 
enrollees, 5.0 percent among full coverage MassHealth 
enrollees in the MCO and PCC programs (mostly due to an 
increase in health risk), and 0.3 percent among Original 
Medicare enrollees. 
• Prescription drug and hospital outpatient department 
spending were the highest growth areas in 2016, with 
increases in spending of 6.1 percent net of rebates and 
5.5 percent from 2015, respectively.
• In Massachusetts, employer-sponsored insurance premi-
ums have grown more slowly in recent years compared 
to the U.S. overall. In 2012, family premiums were about 
11 percent higher in Massachusetts compared to the U.S. 
average; in 2016, family premiums were 7 percent higher 
in Massachusetts. The average annual family premium 
plus cost-sharing for employer coverage in Massachusetts 
in 2016 was $21,085. 
• While Massachusetts employer-sponsored insurance 
premiums are still among the nation’s highest, Massa-
chusetts Health Connector premiums were the second 
lowest in the U.S. in 2017. 
 ○ Employer-sponsored insurance premiums in Massa-
chusetts are fourth highest in the country, while the 
premium cost for a benchmark plan on the Massa-
chusetts Connector was 31 percent below the average 
in ACA exchanges and second lowest in the country.
• The number of people getting health insurance through 
smaller employers dropped by 8 percent between 2014 
and 2016, consistent with fewer small employers offering 
coverage. Enrollment in the individual market, most 
of which is offered through the Massachusetts Health 
Connector, has grown over this time.
OPPORTUNITIES TO IMPROVE QUALITY 
AND EFFICIENCY
• Care delivered in hospital outpatient departments is a 
high growth category of spending. While some hospital 
outpatient spending is high-value, the use of hospi-
tal-based care when the same services could be provided 
in a non-hospital setting may result in unnecessary higher 
spending.
 ○ Massachusetts residents are more likely to see pro-
viders in hospital settings rather than non-hospital 
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settings. For example, Original Medicare beneficiaries 
in Massachusetts use hospital outpatient departments 
for routine visits at twice the national rate (21 percent 
of routine office visits in Massachusetts took place 
in hospital settings, compared to 11 percent in the 
U.S.). Given that Medicare prices for routine visits are 
twice as high in the hospital outpatient department 
compared to an office setting, the higher hospital out-
patient department use rate results in an additional 
$56 million a year spent in Massachusetts.
• Across many categories of health care utilization, there 
are some recent positive trends, as well as some areas for 
continued improvement. 
 ○ Massachusetts residents continue to use more hospital 
outpatient, inpatient, and emergency department (ED) 
care than the nation overall, though the gaps have 
closed by roughly one-third between 2011 and 2015.
 ○ Access to behavioral health care remains an area for 
improvement. The rate of behavioral-health ED visits 
among Massachusetts residents increased 22 percent 
from 2011 to 2016.
 ○ The percentage of community-appropriate inpatient 
care treated at Massachusetts community hospitals 
continued to decline in 2016 to 58 percent from 60 
percent in 2011.
 ○ Trends in post-acute care indicate shifts away from 
use of institutional settings. Between 2014 and 2016, 
the share of discharges to institutional post-acute 
care fell 1.3 percentage points, in large part due to 
reductions among discharges for musculoskeletal 
conditions and reductions among certain hospitals. 
• There was considerable variation in risk-adjusted spend-
ing and utilization outcomes for patients depending on 
their provider organization. Spending varied by more 
than 30 percent between the highest (Partners) and 
lowest-spending organization (Reliant) in 2015, even 
accounting for patient health risk. Provider organiza-
tions anchored by academic medical centers tended to 
have higher spending than physician-led organizations. 
 ○ The variation was primarily driven by hospital out-
patient spending, which varied two-fold between the 
highest and lowest-spending organization. 
 ○ Hospital inpatient, lab, and pharmacy spending 
tended to follow the same general patterns by orga-
nization type.
• ED visits and avoidable ED visits also varied two-fold 
across organizations in 2015, even adjusting for additional 
patient characteristics such as income of their zip code 
of residence, health risk, age, gender, and insurance 
product details. 
PROGRESS IN ALIGNING INCENTIVES FOR 
EFFICIENT AND HIGH QUALITY CARE
• Use of alternative payment methods (APMs) among 
commercial payers increased overall in 2016, reflecting 
different trends by payer type. 
 ○ APM use among the three largest Massachusetts pay-
ers increased sharply from 46 percent to 56 percent of 
covered lives in 2016. However, the rate remained at 
36 percent among other Massachusetts-based carriers, 
which increased their market share in 2016. APM use 
among national carriers in Massachusetts – which 
cover 20 percent of the commercial population – is 
very low, totaling only 2 percent of their covered lives 
(see Chartpack). 
• Uptake of tiered and limited network insurance prod-
ucts grew slightly in 2016, though the increase in tiered 
network plans was entirely due to plans offered to state 
employees enrolled through the Group Insurance Com-
mission (GIC) (see Chartpack).
ReCoMMenDaTIons
In light of these findings and the HPC’s other analytic and 
policy work throughout the year, the HPC makes the follow-
ing recommendations to advance the goal of better care and 
better health at a lower cost for the people of Massachusetts:
RECOMMENDATIONS TO STRENGTHEN 
MARKET FUNCTIONING AND 
SYSTEM TRANSPARENCY
1. Pharmaceutical spending: The Commonwealth 
should take action to reduce increases in drug spend-
ing, and payers and providers should consider further 
opportunities to maximize value. Specific areas of 
focus should include authorizing reforms in the Mass-
Health program, increasing price transparency and 
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accountability, adding pharmaceutical and medical 
device manufacturers as Cost Trends Hearing witnesses, 
using value-based benchmarks and contracts, using 
treatment protocols and guidelines, and enhancing pro-
vider education and monitoring of prescribing patterns.
2. Out-of-network billing: The Commonwealth should 
enhance out-of-network (OON) protections for consum-
ers. Specific actions should include requiring advanced 
patient notification, consumer billing protections in 
emergency and “surprise” billing scenarios, and reason-
able and fair reimbursement for OON services.
3. Provider price variation: The Commonwealth should 
reduce unwarranted variation in provider prices through 
advancing data-driven interventions and policies in the 
coming year.
4. Facility fees: The Commonwealth should take action 
to equalize payments for the same services between 
hospital outpatient departments and physician offices. 
Specific actions should include establishing limits on 
sites that can bill as hospital outpatient departments 
and implementing site-neutral payments for select 
services.
5. Demand-side incentives: The Commonwealth should 
encourage payers and employers to enhance strategies 
that empower consumers to make high-value choices. 
Specific areas of focus should include encouraging 
employees to choose high-value plans; encouraging 
employers to purchase health insurance through the 
Massachusetts Health Connector; improving the design 
of tiered and limited network plans, and testing new 
ideas such as primary care provider tiering; and encour-
aging broad use of CHIA’s new CompareCare website.
RECOMMENDATIONS TO PROMOTE AN 
EFFICIENT, HIGH-QUALITY HEALTH CARE 
DELIVERY SYSTEM
6. Social determinants of health: The Commonwealth 
should emphasize the importance of social determi-
nants of heath on health care access, outcomes, and cost. 
Specific areas of focus should include flexible funding to 
address health-related social needs, inclusion of social 
determinants in payment policies and performance 
measurement, and research and evaluation of innova-
tive interventions and policies to build the evidence base.
7. Health care workforce: The Commonwealth should 
support advancements in the health care workforce 
that promote top-of-license practice and new care team 
models. Specific actions should include scope of prac-
tice reform, including removing restrictions that are 
not evidence-based; establishing a new level of dental 
practitioner for expanded oral health care access; sup-
porting new care team models, particularly to address 
patients’ behavioral health and health-related social 
needs; and engaging the health care workforce in cost 
containment and delivery reform efforts.
8. Innovation investments: The Commonwealth should 
continue to support targeted investments to test, evalu-
ate, and scale innovative care delivery models. Emerging 
ideas that should be considered for funding include 
pharmacologic treatment for substance use disorder 
in primary care settings; telehealth, particularly to 
enhance access to care for certain high-need services 
and patient populations; and mobile integrated health, 
in which community paramedicine and other providers 
treat patients in their homes and communities.
9. Unnecessary utilization: The Commonwealth should 
focus on reducing unnecessary utilization and increas-
ing the provision of care in high-value, low-cost settings, 
consistent with the HPC’s improvement targets. Policy-
makers and market participants should seek progress 
on avoidable emergency department utilization, avoid-
able hospital admissions and readmissions, treating 
low-acuity conditions in community hospitals rather 
than academic medical centers and teaching hospitals, 
and unnecessary institutional post-acute care.
10. Alignment and improvement of APMs: The Com-
monwealth should continue to promote the increased 
adoption of alternative payment methods (APMs) and 
improvements in APM effectiveness. Specific areas of 
focus should include increasing APM coverage in the 
commercial market, aligning quality measurement in 
APMs, adopting HPC Accountable Care Organization 
certification standards, incorporating bundled pay-
ments, and reducing disparities in budget levels.
CHAPTER 1: 
InTRoDUCTIon




The Health Policy Commission (HPC), created in 2012, is 
charged with monitoring health care spending growth in 
Massachusetts and providing data-driven policy recommen-
dations regarding health care delivery and payment system 
reform (see Sidebar: “What is the role of the Health 
Policy Commission?”). In this annual Cost Trends Report, 
the HPC examines key cost drivers and evaluates the state’s 
progress in meeting several cost containment, care deliv-
ery, and payment system goals. The Report includes a set 
of policy recommendations and targets for the Common-
wealth to consider in our collective work toward a high-value, 
well-functioning health system. 
The HPC’s work is driven by the following principles:
• Fostering a value-based market in which payers 
and providers openly compete, and in which provid-
ers are supported and equitably rewarded for providing 
high-quality and affordable services; 
• Supporting an efficient, high-quality, health care 
delivery system that improves health by delivering coor-
dinated, patient-centered health care that accounts for 
patients’ behavioral, social, and medical needs;
• Advancing aligned and effective financial incentives 
for providers to deliver high-quality, cost-effective care 
and for consumers and employers to make high-value 
choices for their care and coverage; and
• Enhancing transparency through publicly avail-
able data and information on health care system 
performance necessary for providers, payers, patients, 
employers, and policymakers, including state agencies 
and the Legislature, to successfully implement reforms 
and evaluate performance over time.
The present-day context in which this Report is published 
is one of both challenge and promise. Massachusetts has 
the lowest rate of uninsured residents in the U.S., having 
undertaken health reform before the federal Patient Pro-
tection and Affordable Care Act (ACA) passed in 2010. The 
Commonwealth continues to rank among the top five states 
in the Commonwealth Fund’s state scorecard both overall 
and within the categories of access, prevention and treat-
ment, healthy lives, and equity.1 Health care spending growth 
in Massachusetts was again below the national rate in 2016, 
marking the seventh consecutive year in which this has 
been the case. Yet Massachusetts remains a high-cost state, 
moving from the most costly state in 2009 to the second 
costliest state in 2014 (see Exhibit 1.1). 
eXHIbIT 1�1 Total per-capita health care spending by state, 2009 and 2014
sources: Centers for Medicare and Medicaid Services State Health Expenditure Accounts, 2009 and 2014
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In 2014, state residents spent $2,500 more per person on 
health care than residents of other states on average and 
more than residents of any state but Alaska. Importantly, 
Massachusetts had the 4th lowest rate of spending growth 
among states since 2009, but low growth must be sustained 
for many years to approach national average spending lev-
els (which are still much higher than spending in other 
high-income countries).2 
The high level of health care spending in Massachusetts does 
not appear to be justified by significantly higher quality of 
care. While Massachusetts includes a number of national-
ly-recognized health care institutions, the quality of care at 
acute hospitals in Massachusetts was similar, on average, to 
national levels, and hospital readmissions rates are higher 
than most states.i Consistent with these data, the Common-
wealth Fund’s scorecard ranked Massachusetts 39th in the 
nation for avoidable hospital use and costs, worsening from 
a ranking of 31st the previous year. 
Excessive health care costs are crowding out spending on 
other priorities for government, households, and businesses. 
For an average Massachusetts family in 2015 with employ-
er-based coverage, health care spending comprised more 
than a quarter of the family’s income – a share that will 
continue to rise if premiums grow faster than wage growth.3 
Recognizing this, Chapter 224 of the Acts of 2012, the compre-
hensive health care reform legislation that established the 
HPC, set a statewide target for a sustainable rate of growth of 
total health care expenditures. From 2013 to 2017, the bench-
mark rate was set at 3.6 percent growth. From 2015 to 2016, 
the growth in total health care spending in Massachusetts 
was 2.8 percent, below the state’s benchmark of 3.6 percent. 
In this Report, the HPC presents the results of its recent 
research to further enhance the state’s understanding of 
these health care spending trends and cost drivers. In addi-
tion, the HPC identifies opportunities for improving the 
quality and efficiency of the health care system in support 
of the Commonwealth’s goal of sustaining spending growth 
in line with the health care cost growth benchmark. 
HoW THIs RePoRT Is oRGanIZeD
This Report is informed by the work of the Attorney Gen-
eral’s Office (AGO) and the Center for Health Information 
and Analysis (CHIA), as well as by presentations at and 
testimony submitted during the HPC’s 2017 Annual Cost 
i HPC analysis of data of the Center for Medicare & Medicaid Services 
Geographic Variation Public Use File.
Trends Hearing. The Report includes material in two formats, 
a narrative written report and a graphical chartpack. 
In the written report, Chapters 2 through 4 compare health 
care cost growth in 2016 against the state’s health care cost 
growth benchmark and discuss trends and levels of health 
care spending in Massachusetts and the nation overall; 
examine trends associated with spending for hospital out-
patient department services; and analyze variation among 
provider groups in health care spending and utilization of 
care among their patients. Chapter 5 contains the HPC’s 
recommendations for accelerating efficiency in health care 
spending in Massachusetts and improving quality of care, 
as well as a dashboard summarizing performance in the 
Commonwealth on key measures.
The chartpack, produced for the first time this year, presents 
updated results and trends previously reported on by the 
HPC. These include areas for improvement in care delivery 
performance, such as avoidable hospital and emergency 
department utilization, and maximizing value in post-acute 
care. The chartpack also analyzes progress in aligning incen-
tives, including use of alternative payment methods (APM) 
and demand-side incentives (DSI).
What is the role of the Health Policy 
Commission?
The Health Policy Commission (HPC) is an independent 
state agency that develops policy to reduce health care 
cost growth and improve the quality of patient care. 
The HPC’s mission is to advance a more transparent, 
accountable, and innovative health care system through 
its independent policy leadership and investment pro-
grams. The HPC’s goal is better health and better care 
– at a lower cost – across the Commonwealth.
The agency’s main responsibilities are led by HPC staff 
and overseen by an 11-member Board of Commissioners. 
HPC staff and commissioners work collaboratively to 
monitor and improve the performance of the health 
care system. Key activities include setting the health 
care cost growth benchmark; setting and monitoring 
provider and payer performance relative to the health 
care cost growth benchmark; creating standards for 
care delivery systems that are accountable to better 
meet patients’ medical, behavioral, and social needs; 
analyzing the impact of health care market transactions 
on cost, quality, and access; and investing in community 
health care delivery and innovations.
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i From 2018 to 2022, the benchmark was set by law to equal potential gross state product minus 0.5 percent, or 3.1 percent, unless the HPC’s board 
votes to maintain the benchmark at 3.6 percent. On March 29, 2017, the board voted unanimously to allow the benchmark to drop to 3.1 percent 
for the 2018 calendar year relative to 2017. Performance against this lower benchmark will be assessed in the HPC’s 2019 Cost Trends Report.
ii 2014 and 2015 spending were revised downward from $54.8 billion and $57.4 billion to $54.3 billion and $57.2 billion, respectively. Much of the 
2014 revision was based on a categorization error by United Health Care which resulted in double-counting of roughly $600 million worth of 
spending on Medicare enrollees. These revisions resulted in changes in previously-reported THCE growth of 4.1 percent from 2014-2015 to 4.8 
percent.
iii This figure is preliminary.
The Commonwealth’s landmark health care cost contain-
ment law, Chapter 224 of the Acts of 2012,1 establishes a 
benchmark against which annual growth in health care 
spending is evaluated, recognizing that containing spend-
ing growth is critical to easing the burden of health care 
spending on government, households, and businesses. 
Chapter 224 directs the Health Policy Commission (HPC) 
and the Center for Health Information and Analysis (CHIA) 
to monitor health care spending growth annually relative 
to the Commonwealth’s economic growth. The benchmark 
is tied to potential gross state product with the intention of 
maintaining a roughly constant share of the state economy 
devoted to health care spending. From 2013 to 2017, the 
benchmark has been set at 3.6 percent.i
In keeping with the mandate to monitor 
spending against the benchmark, and value 
and performance in the health system 
overall, this chapter discusses the state’s 
performance relative to the benchmark in 
2016 and broad trends affecting health care 
spending in the Commonwealth.
sPenDInG GRoWTH fRoM 
2015 To 2016
The measure of spending growth that is 
compared to the benchmark is defined as the 
change in Total Health Care Expenditures 
(THCE, as defined by CHIA) per state resi-
dent. THCE includes health care spending 
incurred by individuals, the state, and the 
federal government via Medicaid (Mass-
Health) and Medicare, as well as commercial 
spending as reported by health insurers to CHIA. From 2015 
to 2016, CHIA reported that the initial per capita growth in 
THCE in Massachusetts was 2.8 percent, below the state’s 
benchmark of 3.6 percent.2 Total spending increased from 
$57.2 billion in 2015ii to $59.0 billion in 2016,iii while the 
state’s population was estimated to have grown from 6.78 
million to 6.81 million residents over the same time period, 
resulting in an increase in per capita spending from $8,429 
to $8,663. This marks the second year of performance below 
the benchmark rate in the four years since the passage of 
Chapter 224 for which THCE growth can be assessed. The 
average annual growth rate over the four years is 3.55 percent, 
just below the benchmark rate (see Exhibit 2.1).
eXHIbIT 2�1 Annual growth in total health care expenditures per 
capita in Massachusetts
note: 2015-2016 spending growth is preliminary.
source: Center for Health Information and Analysis Annual Report, 2017
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Total spending growth was relatively similar across the 
three major market segments (Medicare, MassHealth, and 
commercial) but there were important differences in terms of 
changes in enrollment and changes in spending per enrollee 
(see Exhibit 2.2).
Spending growth per commercial enrollee was below the 
3.6 percent benchmark rate in 2016. However, within the 
commercial sector, important differences continue between 
the individual and employer markets (see Chartpack). Pre-
miums for individuals enrolled in the individual market, 
most of whom obtain insurance through the Massachusetts 
Health Connector, continued to decline further in 2016 after 
declining in 2015 – such that the average individual mar-
ket premium was more than 20 percent below the average 
premium in the employer-based market in 2016. On the 
other hand, premiums in the employer-based insurance 
market increased by 3.9 percent on average in 2016 while 
cost-sharing increased by 5.3 percent.iv
iv Estimates are for the fully-insured market only.
v Some enrollment growth in the individual market in 2016 was due to a transfer of individuals from CommonwealthCare and the MassHealth 
Temporary Coverage program.
vi Offer rates declined from 70% to 59% among establishments with between 3 and 24 employees, which comprise the majority of establishments 
with fewer than 50 employees.
Enrollment trends also diverged, with enrollment growing 
by 59,000 in the individual market in 2016 and declining 
by 24,000 in the employer market, primarily among those 
insured through smaller firms.v The decline in members 
enrolled through smaller firms is consistent with a signifi-
cant drop in rates of offering coverage among establishments 
with fewer than 25 employees (from 70 percent in 2014 to 
59 percent in 2016), as identified in CHIA’s Massachusetts 
Employer Survey.3 ,vi When employers with fewer than 50 
employees were asked in 2016 why they do not offer cover-
age, the most common responses were “employees covered 
under another plan, including coverage under a spouse, 
MassHealth, or the Massachusetts Health Connector” (64%) 
and “[the] firm is not required to offer insurance due to 
small size” (58%).
Per member growth in spending among MassHealth PCC and 
MCO enrollees was 5.0 percent while enrollment declined 
slightly. When adjusted for health status changes, spending 
eXHIbIT 2�2 Change in enrollment and per-enrollee spending by major 
market segment, 2015-2016
notes: Medicare FFS spending does not include Part D prescription drug coverage. Commercial spending 
and enrollment growth includes enrollees with full and partial claims. MassHealth includes only full coverage 
enrollees in the PCC and MCO programs. Figures are not adjusted for changes in health status.
source: Center for Health Information and Analysis Annual Report, 2017
HEALTH POLICY COMMISSION2017 COST TRENDS REPORT - 14 -
CHaPTeR 2: TRenDs In sPenDInG anD CaRe DelIVeRY  
growth among MCO enrollees in 2016 was only 1.1 percent, 
compared to unadjusted growth of 5.9 percent, indicating 
the spending growth was largely explained by fluctuations in 
membership and the health risk of enrolled members. Pre-
scription drug spending was the largest driver of spending 
among this group, growing at a rate of 8.5 percent in 2016.vii
Medicare spending per enrollee in Massachusetts continued 
to grow very slowly in 2016 at 0.3 percent, even below low 
national rates of 0.6 percent in 2016. Yet, consistent with 
trends in population aging nationwide and in Massachusetts, 
enrollment in Medicare grew 2 percent in Fee-For-Service 
(FFS) and 3 percent in Medicare Advantage. This degree of 
enrollment growth is consistent with known trends in the 
aging of the population in Massachusetts, which, by itself, 
is expected to contribute 0.5 percent in THCE spending 
growth each year.4
vii This figure does not include drug rebates.
sPenDInG bY CaTeGoRY of seRVICe
Hospital outpatient and prescription drug spending were 
the fastest-growing categories of spending in 2016, with 
rates of growth of 5.5 percent and 6.1 percent respectively 
(see Exhibit 2.3).
Prescription drug spending growth per member (net of 
rebates) moderated to 4.7 percent in the commercial market 
in 2016 after growing by 6.9 percent in 2015 (see Sidebar: 
Prescription drug spending trends). Drug spending 
growth per member (net of rebates) in Medicare Advan-
tage was unchanged, and spending per member among 
Original Medicare enrollees in Medicare part D decreased 
2.1 percent. However, there was considerable growth in the 
percentage of Original Medicare beneficiaries who enrolled 
in Medicare part D (from 59 percent in 2015 to 66 percent in 
2016), increasing total spending on prescription drugs (net 
of rebates) among those beneficiaries by 11 percent in 2016.
eXHIbIT 2�3 Rates of spending growth in Massachusetts in 2015 and 2016, by category
notes: Pharmacy spending is net of rebates.
source: Payer reported TME data to CHIA and other public sources; appears in Center for Health 
Information and Analysis Annual Report, 2017
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Prescription drug spending trends and state policy
Prescription drugs represented the highest growth sector of health care spending in 2016. Point of sale spending on 
prescription drugs in Massachusetts grew 6.4 percent in 2016, from $8.6 billion to $9.2 billion. However, payers receive 
additional rebates, discounts, and other price concessions from manufacturers that are not reflected in payments at 
the point of sale but lower total drug spending. Accounting for these rebates, prescription drug spending grew 6.1 
percent in 2016, somewhat higher than U.S. net growth estimates of 4.8 percent, although these numbers are not fully 
analogous.5 Growth slowed from 2015, when prescription drug spending grew 7.2 percent net of rebates (12.1 percent 
gross).viii However, annual spending for drugs continues to grow substantially faster than other sectors. Analysts 
estimate mid-single digit growth annually through 2021, based on expectations for new product innovation and price 
growth for existing products, offset by generic and biosimilar competition.5
Importantly, future spending may continue to be impacted by intensified efforts by health plans and pharmacy benefit 
managers to manage spending. For example, following the launch of PCSK9s, a new class of high-cost drugs to man-
age high cholesterol, U.S. payers heavily restricted use of these medications to their FDA approved uses.5 As a result, 
uptake of these drugs was limited in 2016.
Drug spending trends have motivated numerous state level efforts across the country and in Massachusetts to increase 
price scrutiny and competition. Governor Baker has proposed a multi-faceted approach to address increasing costs 
in the MassHealth program. The proposal would allow MassHealth to negotiate directly with manufacturers and 
impose robust transparency requirements in order to establish fair and reasonable cost-effective prices. In addition, 
in September 2017, Massachusetts applied for a waiver from federal Medicaid rules in order to exclude certain drugs 
from the MassHealth formulary, similar to standard practice in commercial plans.6 MassHealth would maintain an 
exceptions process to cover drugs that are not on the formulary when medically necessary. In addition to strengthening 
the linkage between coverage and evidence, MassHealth would be better positioned to negotiate prices for covered 
drugs and promote market competition that can moderate drug prices. The Massachusetts Senate has also proposed 
legislation to increase transparency into drug pricing across the market.7
A number of other states have also considered new drug price transparency legislation this year.7 California passed 
a law in 2017 that requires manufacturers to provide all purchasers with advance notice of price increases above a 
certain threshold and to provide information justifying price increases and high launch prices in certain cases. In 
April 2017, New York created a drug spending cap within its Medicaid program. A Drug Utilization Review Board will 
determine whether to recommend a supplemental rebate for particular drugs based on a drug’s impact on spending, 
justification for price increases, and cost of the drug relative to its therapeutic benefits.
A growing emphasis among state purchasers on clinical effectiveness and cost effectiveness, as well as increased 
scrutiny on prices, could support a more value-based marketplace and moderate future drug spending growth.
viii Net prices for existing brand products grew 3.5 percent in 2016. While this net price growth was higher than the 2.6 percent growth in 2015, it 
was lower than in any previous year since 2011.
Hospital outpatient spending growth was greater in 2016 
than 2015, and continues a longer-term trend of relatively 
high rates of growth compared to other categories of spend-
ing. Growth in hospital outpatient spending can arise from 
a number of factors, including price increases, volume 
increases, and shifting of care from either more costly inpa-
tient settings or less costly non-hospital settings. This year, 
the HPC focuses again on hospital outpatient spending, in 
Chapter 3: Hospital Outpatient Department Spending.
Massachusetts appears to be making some progress in using 
less institutional care. Growth in hospital inpatient spending 
was relatively low in 2016. The total number of inpatient 
hospital visits grew by 0.3 percent in 2016 while hospi-
tal inpatient spending grew 2.2 percent (see Chartpack). 
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Following a hospital discharge, use of institutional post-
acute care— such as skilled nursing facilities— dropped in 
2016, led by a reduction in use for musculoskeletal condi-
tions from 44 percent to 38 percent (see Chartpack). Total 
skilled nursing facility spending among Original Medicare 
beneficiaries in Massachusetts dropped nearly 11 percent 
per beneficiary in 2016.
CoMPaRIson To naTIonWIDe TRenDs
In terms of overall per capita spending growth, the Massa-
chusetts total health care spending growth rate of 2.8 percent 
per capita in 2016 was below the US rate of 3.5 percent, con-
tinuing a consecutive seven year trend of spending growth 
below the national growth rate (see Exhibit 2.4)
Total spending per capita in Massachusetts grew the third 
slowest of all states in the US between 2009 and 2014, which 
reduced the extent by which spending in Massachusetts 
exceeded the national average from 37 percent to 31 percent. 
Much of the reduction came in the areas of hospital spending 
(combined inpatient and outpatient). In 2009, Massachusetts 
residents spent $1,060 more than the national average on 
hospital care, accounting for 42 percent of the total spending 
difference. By 2014, Massachusetts residents spent $850 
more than the national average on hospital care, accounting 
for 34 percent of the excess spending in Massachusetts. In 
contrast, Massachusetts residents spent $950 more than the 
national average on home health and other post-acute care 
in 2014, an increase from $815 more in 2009.
In the commercial sector, per member growth rates also 
continued to be below the national average (see Exhibit 2.5), 
although growth has accelerated each year since 2012.
Cumulatively from 2012 to 2016, these lower growth rates 
amount to commercial spending that has been $5.9B lower 
over this time period than would have been the case if growth 
rates matched the national average. This lower growth is 
reflected in health insurance premiums that have dropped 
relative to the national average. Average family premiums 
for employer coverage were 10.7 percent above the national 
average in 2012 but 7.0 percent above the average in 2016, 
while premiums for single coverage were 13.7 percent higher 
in 2012 and 8.5 percent higher in 2016. Lower growth also 
stems from trends in premiums for individual coverage in 
Massachusetts, mainly through the Massachusetts Health 
sources: Centers for Medicare and Medicaid Services, National Health 
Expenditure Accounts Personal Health Care Expenditures, 2014-
2016 and State Health Expenditure Accounts, 2000-2014; Center 
for Health Information and Analysis, Total Health Care Expenditures 
(MA), 2014-2016
eXHIbIT 2�4 Annual growth in total health care spending 
per-capita in Massachusetts and nationwide
sources: Centers for Medicare and Medicaid Services, National Health 
Expenditure Accounts Personal Health Care Expenditures, 2014-
2016 and State Health Expenditure Accounts, 2000-2014; Center 
for Health Information and Analysis, Total Health Care Expenditures 
(MA), 2014-2016
eXHIbIT 2�5 Annual growth in per-capita commercial health 
care spending, Massachusetts and nationwide
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Connector. These premiums dropped in 2015 and 2016 while 
growing substantially in the rest of the nation (see Chart-
pack) and are now lower than any other state in the nation 
except Washington.
Nevertheless, employer-based health insurance premiums 
in Massachusetts remain the fourth highest in the country, 
with an average family paying nearly $19,000 per year for 
coverage in 2016 and single enrollees paying $6,600 on 
average.8
aCCess To anD affoRDabIlITY of 
CaRe
Massachusetts has long been a leader in advancing access 
to care, particularly since the passage of Chapter 58 of the 
Acts of 2006, the health care access reform law that became 
a model for the Affordable Care Act. The Commonwealth 
continues to have the lowest uninsured rate in the nation 
at 2.5 percent of the population in 2016, which was 6.1 per-
centage-points lower than the national average (8.6 percent).9 
Furthermore, the percentage of Massachusetts residents 
who had difficulty paying their medi-
cal bills decreased slightly from 2015 
to 2017, dropping from 17.0 percent to 
15.8 percent.10 Despite these encouraging 
trends, many Massachusetts residents 
and employers face considerable chal-
lenges with health care affordability.
As noted earlier, the average total 
premium (including both employer 
and employee contributions) for 
employer-based family coverage in 
Massachusetts was $18,955 overall in 
2016; including typical cost sharing 
amounts, the cost of health care totaled 
over $21,085 annually per family. This 
amount is more than the entire annual 
earnings of one in five Massachusetts 
workers.11 Combining premium costs, 
out-of-pocket spending and taxes that 
pay for federal and state health care 
programs, an average Massachusetts family spends more 
than 25 percent of its total income on health care, stretching 
the remainder across other priorities.12
In addition to the affordability challenge posed by rising 
premiums, affordability may be worsening due to increased 
out-of-pocket spending. The proportion of individuals with 
private coverage that are enrolled in high-deductible plans 
grew 2 percentage points in 2016, resulting in more than one 
in five individuals enrolled in high-deductible plans. Results 
from CHIA’s 2017 Massachusetts Health Insurance Survey 
show that almost one in four Massachusetts residents spent 
more than $3,000 out-of-pocket on health care in 2017.9
Two other factors make commercial health care even less 
affordable for lower-income residents who are ineligible 
for subsidies via the Massachusetts Health Connector or 
MassHealth. First, employees of lower-wage firms con-
tributed more toward family premiums than employees of 
higher-wage firms in 2016 (see Exhibit 2.6). This finding 
became even more pronounced between 2015 and 2016.13
eXHIbIT 2�6 Total family premium and employee contribution to premium in 
Massachusetts by the firm’s wage quartile, 2016
notes: Wage quartiles reflect average wages at each firm included in the sample. For 
example, Q1 includes firms with average wages below the 25th percentile.
sources: HPC analysis of Agency for Healthcare Research and Quality, Medical Expen-
diture Panel Survey, 2016
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Second, families who report worse health status faced higher 
burdens of health spending than those in better health, even 
where total income was roughly the same (see Exhibit 2.7).
Relative to families in better health, families with greater 
health needs had higher out-of-pocket costs ($3,840 versus 
$2,443); were more likely not to fill a prescription (16.7 per-
cent versus 3.2 percent), get doctor care (9.4 percent versus 
4.9 percent) or dental care (23.0 percent versus 9.4 percent); 
and, were more likely to have outstanding medical bills (20.4 
percent versus 14.0 percent).
fUTURe oUTlooK
The outlook for success against the state’s spending bench-
mark for growth in 2017 and beyond is uncertain, though 
there are some promising developments underway. For 
example, the MassHealth ACO program, aided by addi-
tional waiver funding from the federal government, will 
launch in early 2018. With the launch of the ACO program, 
APM coverage will increase for MassHealth PCC and MCO 
members, and the added incentives for controlling costs and 
improving care coordination could help reduce spending 
among those enrollees. Some private insurers also report 
implementing payment strategies and incentives oriented 
toward reducing excess spending, such as non-payment for 
some readmissions, use of cash-back and other demand-
side incentives, and further introduction of APMs into PPO 
products.14 National spending trends between 2016 and 2017 
appear similar to trends between 2015 and 2016, including 
trends in prescription drug prices, where state trends tend 
to follow national trends.15
On the other hand, there continues to be uncertainty sur-
rounding federal implementation and policy regarding the 
ACA, particularly the fate of cost-sharing reductions for 
low-income exchange enrollees which were ended in late 2017 
and rules related to Association Health Plans. Consolidation 
of providers also continues, with potential impacts on spend-
ing and market dynamics.16 As always, continued vigilance is 
required to meet the state’s goals with regard to health care 
spending, access, and quality of care for all residents.
notes: Analysis is based on 843 families with employer-sponsored health insurance between 200% and 500% of the federal poverty level, 
representing 1.5 million state residents (across two years). All differences are statistically significant at the 10% level (p<.10) or less and all but 
two (outstanding medical bills and doctor care) are statistically significant at the 5% level (p<.05). Better health is defined as those reporting 
their health is ‘excellent’ or ‘very good’. Worse Health is ‘good’, ‘fair’ and ‘poor’.
sources: HPC analysis of Center for Health Information and Analysis Massachusetts Health Insurance Survey, 2014 and 2015
eXHIbIT 2�7 Differences in utilization and spending for families of similar income but better or worse health status, 2014 and 2015
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CHaPTeR 3:  
HosPITal oUTPaTIenT 
DePaRTMenT sPenDInG
Hospital outpatient departments provide a range of clin-
ical services, from the simple to the complex, including 
regular doctor visits, imaging, emergency department (ED) 
visits, and surgeries. Many hospital outpatient services can 
be performed in alternative settings, including at more 
expensive hospital inpatient settings or at less expensive 
non-hospital settings, such as a physician’s office or a free-
standing imaging center.
In 2016, spending in hospital outpatient departments rep-
resented 18.5 percent of all health care spending in the 
Commonwealth, and spending in this sector has among the 
highest growth rates. Across all payers, hospital outpatient 
department spending increased 5.5 percent from 2015 to 
2016 and 3.5 percent from 2014 to 2015 (see Exhibit 2.3 
in Chapter 2). Growth in hospital outpatient department 
spending in Massachusetts appears similar to trends in 
the U.S. overall: hospital outpatient spending for Original 
Medicare beneficiaries grew 5.2 percent per year in Massa-
chusetts between 2013 and 2016, compared to 4.8 percent 
per year in the U.S.i
Hospital outpatient use varies widely by region and by pro-
vider system (see Chapter 4 for detail on provider system 
variation), but on average, patients in Massachusetts have 
much higher levels of hospital outpatient department use 
compared to the nation overall. In 2015, hospital outpatient 
visits per Medicare beneficiary in Massachusetts exceeded 
the U.S. average by 49 percent (see Chartpack). Massa-
chusetts Medicare beneficiaries spent $477 more annually 
per beneficiary on hospital outpatient care than the U.S. 
average in 2016.ii
Multiple dynamics influence hospital outpatient use and 
spending growth. Growth in hospital outpatient spending 
does not by itself indicate that spending is unwarranted; 
for example, shifting higher-cost inpatient care to outpa-
tient care could represent an improvement in efficiency. 
This chapter identifies drivers of growth and highlights 
i HPC analysis of data supplied to the HPC by the Center for Medicare & Medicaid Services
ii While Massachusetts has higher utilization than the national rate for other hospital services as well, these differentials are lower; Massachusetts 
ED and hospital inpatient visits per capita were 9 percent and 8 percent the national average in 2015, respectively.
opportunities for more efficient spending, particularly in 
the area of shifts to hospital outpatient departments from 
less expensive non-hospital settings.
CoMPonenTs of HosPITal 
oUTPaTIenT DePaRTMenT sPenDInG
Hospital outpatient spending consists of different types of 
services, which have grown at different rates (see 
Exhibit 3.1). Outpatient surgery, in which the patient typ-
ically requires hospital care for less than 24 hours and 
includes procedures such as a colonoscopy, represented 
about one-third of hospital outpatient spending in 2015. It 
was also one of the fastest growing categories of hospital 
outpatient spending, growing 14 percent between 2013 and 
2015 and accounting for 75 percent of total hospital outpa-
tient spending growth between 2013 and 2015 in the 
eXHIbIT 3�1 Commercial spending per member per year in 
Massachusetts by hospital outpatient service category, 2015, 
and contribution to spending growth, 2013 - 2015
notes: 2013 data were adjusted to match commercial TME growth in 
hospital outpatient spending as reported by CHIA between 2013 and 
2014. Hospital outpatient includes all outpatient spending billed on 
a facility claim for a Massachusetts acute-care facility. See Technical 
Appendix for details.
sources: HPC analysis of Massachusetts All-Payer Claims Database, 
2013-2015
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commercial population. Spending on administered drugsiii 
(including payments for the drugs and the administration) 
also grew 14 percent between 2013 and 2015 and accounted 
for 23 percent of outpatient spending growth between these 
years. ED visits accounted for 11 percent of growth.
faCToRs ConTRIbUTInG To CHanGe In 
VolUMe of seRVICes
SHIFTS BETWEEN INPATIENT AND 
OUTPATIENT SETTINGS
Over the past several decades, more surgical procedures have 
been moving from the inpatient to the outpatient setting, 
largely due to advancements in medical technology. In 2014, 
66 percent of surgeries in the U.S. were performed in an 
outpatient setting, compared with 51 percent in 1990 and 
16 percent in 1980.1 Technological innovation has enabled 
patients to undergo less invasive procedures and recover 
faster. For example, surgical procedures have become eas-
ier to deliver in an outpatient setting due to advances in 
minimally invasive procedures, better anesthesia, and more 
effective therapies to manage pain at home.2 Literature 
suggests that these improvements have not only driven a 
shift to the outpatient setting, but also led to an increase in 
total volume of procedures.3 In 2016, outpatient spending 
accounted for 56 percent of all hospital revenue among 
community hospitals in Massachusetts, and 50 percent and 
45 percent of hospital revenue among teaching hospitals 
and academic medical centers, respectively.iv
To further analyze shifts in hospital care, the HPC examined 
trends for five “cross-over” procedures commonly performed 
in both settings: laparoscopic cholecystectomy, laparoscopic 
appendectomy, arthrodesis, laparoscopic total hysterectomy, 
and laparoscopic vaginal hysterectomy.v Between 2011 and 
2015, the setting of care for these procedures changed dra-
matically (see Exhibit 3.2), with a fairly even split between 
inpatient and outpatient settings in 2011 shifting to 78 per-
cent of these procedures being performed on an outpatient 
iii Drugs administered in a hospital outpatient department are typically covered under a patient’s medical benefit, rather than prescription drug 
benefit. Examples of these administered medical drugs include chemotherapy agents and flu vaccines.
iv Based on analysis of Center for Health Information and Analysis’ FY 2015 Massachusetts Hospital Profiles.
v Procedures were selected based on the highest volume billed by surgeons in 2013, where at least 10 percent of the surgeries occurred at an inpa-
tient hospital and at least 10 percent occurred in an outpatient setting.
vi Controlling for a change in the number of member months in the database between 2011 and 2015, the total number of procedures increased by 
0.3 percent.
vii Inpatient prices increased more than outpatient prices. Between 2011 and 2013, growth in inpatient prices for the five procedures ranged from 
12 to 21 percent, while growth in outpatient prices ranged from 4 to 17 percent.
basis in 2015. Between 2011 and 2015, the total number of 
these procedures remained relatively constant.vi
An earlier HPC analysis of trends in these procedures from 
2011 to 2013 found that total spending on these five proce-
dures grew slightly, but spending growth would likely have 
been higher without the shifts in setting of care.4 Prices 
grew in both the inpatient and outpatient settings, with 
price growth appearing to have consumed potential savings 
from the shift in site of care.vii
notes: The five cross-over procedures were identified as the high-
est-volume procedures billed by surgeons in 2013 where at least 10 
percent of the surgeries occurred at an inpatient hospital and at least 10 
percent occurred in an outpatient setting. Procedures are laparoscopic 
cholecystectomy, laparoscopic appendectomy, arthrodesis, laparo-
scopic total hysterectomy, and laparoscopic vaginal hysterectomy.
sources: HPC analysis of Massachusetts All-Payer Claims Database, 
2011-2015
eXHIbIT 3�2 Share of volume by setting for five cross-over 
surgical procedures performed in hospitals, 2011 - 2015
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SHIFTS BETWEEN NON-
HOSPITAL AND HOSPITAL 
OUTPATIENT SETTINGS
In contrast to shifts from inpatient care, shifts 
from non-hospital settings (such as a physi-
cian’s office or a freestanding imaging center) 
to hospital outpatient settings have the poten-
tial to increase spending unnecessarily and 
represent an important opportunity for policy 
attention.
Prices tend to be substantially higher in hospital 
outpatient departments than in non-hospital 
settings, reflecting in part the fact that hospital 
outpatient departments may require costly 
facility overhead, such as infrastructure for 
complex surgeries and maintaining 24-hour 
access to emergency departments. However, 
higher compensation for this costly facility 
overhead generally applies to all services per-
formed in a hospital outpatient department, 
even to services that could safely and effectively 
be performed in lower cost non-hospital set-
tings, such as routine doctor’s visits or simple 
cardiac imaging. Whereas payment for services 
performed in a doctor’s office usually combines 
compensation for professional services and 
overhead into one fee, some payers provide 
separate payments for professional and over-
head components (or “facility fees”) when the 
service is performed in a hospital outpatient 
department (see Sidebar: Hospital outpatient 
department prices).
Among commercial payers in Massachusetts, 
prices in 2015 for a knee MRI were 38 percent 
higher when performed in a hospital outpa-
tient department compared to a non-hospital 
setting such as a freestanding imaging center 
(see Exhibit 3.3). Prices for a colonoscopy aver-
aged 60 percent higher in a hospital outpatient 
setting, compared to a non-hospital setting.
Differences in prices between settings are also 
very substantial in the Medicare program (see 
Exhibit 3.4 and Sidebar: Hospital outpatient 
department prices).
eXHIbIT 3�3 Comparison of mean commercial prices for select 
services by setting, 2015
notes: The Current Procedural Terminology codes used are 73721 (knee MRI), 
45378 (colonoscopy), and 43239 (upper GI endoscopy). Spending includes insurer 
and enrollee payments for both the facility and professional portion of the service, 
on all claim lines for the same patient on the same date with the same CPT code.
sources: HPC analysis of Massachusetts All-Payer Claims Database, 2015
notes: Prices reflect Medicare allowed amount for services, including the professional 
and facility fee components. Professional services are paid under the Medicare Physician 
Fee Schedule (MPFS). Facility fees are paid under the Outpatient Prospective Payment 
System (OPPS). The Current Procedural Terminology codes used are 99211-99215 
(evaluation & management visits), 70551 (MRI scan of the brain), and 93306 (echo-
cardiogram). The hospital outpatient category includes settings for which Medicare 
reimburses professional services at a facility rate.
sources: HPC analysis of Center for Medicare and Medicaid Services, Medicare Phy-
sician and Other Supplier Public Use File, 2015 and Hospital Outpatient Prospective 
Payment Final Rule, CY2015.
eXHIbIT 3�4 Comparison of Medicare prices for select services 
by setting, 2015
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Hospital outpatient department prices in the Medicare program and other settings
In the Medicare payment system, payments for services provided in a hospital outpatient department have two com-
ponents: a professional fee and a facility fee. This facility fee is intended to reflect additional high overhead costs 
associated with a hospital outpatient department (e.g., equipment and ancillary staff to provide complex surgeries, 
requirements to provide 24-hour care). In contrast, payments for services provided in a physician’s office have only a 
professional fee component. This fee is higher than the professional fee in a hospital outpatient department because 
it includes both professional costs and facility costs associated with overhead in a physician’s office.
The combined payment amount for a service provided in a hospital outpatient department is substantially more than 
the payment for the same service provided in a physician’s office. For example, the Medicare payment for a regular 
office visit in a hospital outpatient department is more than double the payment for the same service provided in a 
freestanding practice (see Exhibit 3.5). Because Medicare patients are responsible for paying a percentage of the cost 
of their care, patient cost-sharing is also double when this service is provided in a hospital outpatient department.
Many commercial payers tend to adopt Medicare payment rules. Therefore, commercial patients may receive two bills 
for a service provided in a hospital outpatient department, known as “split billing”: a bill for professional services and 
a second bill for the hospital facility fee. While some commercial payers do not allow “split billing,” further research 
is needed on whether these restrictions result in lowering total payments or whether hospitals respond by shifting 
their billing practices to seek higher total payments under a single bill.
The HPC has found that volume has shifted for a number 
of services from non-hospital settings to hospital outpa-
tient departments. One important factor in this shift is 
the increase in physician affiliation with hospitals, which 
can include contracting affiliations and hospital acqui-
sition of physician groups. Affiliations can shift care to 
hospital outpatient departments through new in-system 
referral patterns that bypass non-hospital settings in favor 
of hospital-based care. In addition, hospital acquisition of 
physician practices can increase spending without changing 
where services are delivered. When hospitals acquire phy-
sician groups, they may license physician offices as satellite 
non-hospital 







facility fee Total hospital  based rate
Medicare program payment $64�53 $44.87 $92.38 $137�26
Beneficiary cost sharing $16�13 $11.22 $23.10 $34�31
Total payment $80�66 $56.09 $115.48 $171�57
*includes payment for overhead
eXHIbIT 3�5 Differences in Medicare program payments and beneficiary cost sharing for office visits provided in 
hospital outpatient departments and freestanding physician offices in Massachusetts, 2015
notes: Prices reflect Medicare allowed amount for services. Professional services paid under the Medicare physician fee schedule 
(MPFS). Facility fees paid under the Outpatient Prospective Payment System (OPPS). The Current Procedural Terminology codes used 
for evaluation & management visits are 99211-99215; prices for professional services are a weighted average of these codes. The 
Healthcare Common Procedure Code Set code for evaluation & management visits under OPPS is G0463.
sources: HPC analysis of Center for Medicare and Medicaid Services, Medicare Physician and Other Supplier Public Use File, 2015 
and Hospital Outpatient Prospective Payment Final Rule, CY2015.
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hospital outpatient departments. In these cases, the 
hospital bills on behalf of the physician office at the 
higher hospital outpatient department rates for the 
same service at the same location.viii
To analyze these trends, the HPC used Original Medi-
care data to compare use of select services by setting 
over time in Massachusetts and in the U.S.ix In all cases, 
a larger share of services was provided in hospital 
outpatient departments in Massachusetts than in the 
U.S. in 2015, and the share of services provided in a 
hospital outpatient department increased in all cases 
between 2012 and 2015 (see Exhibit 3.6).
For Evaluation & Management (E&M) visits (routine 
doctor visits),x Medicare beneficiaries in Massachu-
setts use hospital outpatient departments at twice 
the national rate. In 2015, 21 percent of E&M visits in 
Massachusetts took place in hospital settings, com-
pared to 11 percent in the U.S overall. This higher use 
of hospital outpatient departments for doctor visits 
translates to an average cost per visit that is 10 percent 
higher than it would be otherwise (an average of $99.75 
versus $90.57), resulting in an additional $56 million 
in spending per year. While this represents a single 
high-volume example, similar excess costs are paid 
across many other services such as those included in 
Exhibit 3.6.
Payers are increasingly implementing reforms to 
address the shifts in site of care and the disparity in 
prices for services rendered at hospital outpatient 
departments for services that could be safely provided 
in lower-cost settings (see Sidebar: Payer policies 
regarding hospital outpatient departments). The 
findings in this chapter support the need for further 
action in this area to ensure efficient health care 
spending.
viii See 2015 Cost Trends Report for additional detail on this trend 
in Massachusetts and the U.S.
ix Services were selected from a set that the Medicare Payment 
Advisory Commission has identified as comparable between 
settings on the basis of complexity and patient acuity (see 
Medicare Payment Advisory Commission. Report to the Con-
gress: Medicare and the health care delivery system. 2013 June).
x Defined as CPT codes 99211-99215. Prices discussed in this 
section reflect a weighted average of payments for these codes.
notes: The Current Procedural Terminology (CPT) codes used for Eval-
uation & Management visits are 99211-99215; prices for professional 
services are a weighted average of these codes. CPT code 70551 was 
used for MRI, and CPT code 93306 was used for echocardiogram.
sources: HPC analysis of Center for Medicare and Medicaid Services, 
Medicare Physician and Other Supplier Public Use File, 2015.
eXHIbIT 3�6 Use of select services by setting among Medicare ben-
eficiaries in Massachusetts and the U.S., 2012 and 2015
Evaluation & management visits (99211 - 99215), 2012 and 2015
Echocardiogram (93306), 2012 and 2015
MRI scan of the brain (70551), 2012 and 2015
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Payer policies regarding hospital outpatient departments
Refine site definition: Limit the types of provider locations that can bill payers and patients as a hospital 
outpatient department
The ability to earn higher payment rates as a hospital outpatient department than as a physician office 
has incentivized the practice of hospitals acquiring physician practices and billing for those practices as 
hospital outpatient departments. In November 2015, Congress took action to limit this practice for Medi-
care payments,5 codifying CMS’ definition of provider-based off-campus hospital outpatient departments. 
Under the law, providers located 250 yards away or more from a hospital’s main campus are not be eligible 
to receive hospital outpatient payment rates from Medicare. This change, effective January 1, 2017, is pro-
jected to save $9.3 billion over 10 years.
Notably, there are two significant exceptions to the law: 1) providers that have already billed as an outpatient 
department prior to passage of the law (November 2, 2015) are still eligible for reimbursement as hospital 
outpatient departments; and 2) providers with dedicated EDs.
Site-neutral payment: Require uniform rates between hospital outpatient departments and non-hospital 
settings for select services
For the Medicare program, both CMS and the Medicare Payment Advisory Commission (MedPAC) have 
proposed options for “site neutral payments,” where payment rates would be the same or similar for ser-
vices regardless of where the services are performed. The payment rate would be based on the rate for the 
lower-cost setting. For example, MedPAC has recommended lowering hospital outpatient department rates 
for E&M visits and a select set of other services such that Medicare payment rates for these services would 
be the same in free-standing physician offices and hospital outpatient departments.6
Commercial payers have also increasingly focused on reducing higher payments based solely on site of 
care. For example, Blue Cross Blue Shield of Massachusetts reports that, beginning in 2015, it does not 
reimburse for hospital facility fees billed with routine E&M services.xi
Taking a different approach, Anthem Blue Cross Blue Shield, a national insurer, will no longer pay for MRIs 
or CT scans performed at hospital outpatient departments when they can be performed at freestanding 
imaging centers.7 Anthem began implementing this non-payment policy in some states in July 2017, and 
the insurer plans to extend the policy to additional states by March 2018.xii Compared to site-neutral pay-
ment policies, Anthem’s non-payment policies may be easier to administer but place the responsibility for 
electing site of care with patients, potentially leaving patients with large bills for services if they mistakenly 
use a non-covered site.
xi Pre-filed testimony for the 2015 Cost Trends Hearing
xii By March 2018, Anthem plans to have the policy implemented in California, Colorado, Connecticut, Georgia, Indiana, Kentucky, 
Maine, Missouri, Nevada, New York, Ohio, Virginia, and Wisconsin. Anthem also operates in New Hampshire, but has stated that 
it does not plan to implement the policy there.
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baCKGRoUnD
In recent years, the Health Policy Commission (HPC) has 
reported on several measures of variation across health care 
provider organizations in Massachusetts including total 
spending and rates of provision of low-value services. This 
year, for the first time, the HPC has linked the Registration 
of Provider Organizations (RPO) data and the All-Payer 
Claims Database (APCD) using patient attribution models, 
significantly expanding the ability to compare spending 
and utilization outcomes across provider organizations. A 
greater understanding of provider variation and the drivers 
of variation can foster improvement among peer organiza-
tions, provide more information to payers and purchasers 
of care, and enable policymakers to encourage better per-
formance through incentives.
The following analyses compare provider organizations by 
averaging spending and utilization across commercially 
insured patients whose primary care providers (PCPs) are 
affiliated with, or owned by, a given organization. Impor-
tantly, all spending and utilization across all sites of care 
(e.g., specialist, inpatient, post-acute) for these patients is 
attributed to the PCP and its affiliated provider organization, 
regardless of whether the care was actually delivered by that 
provider organization. For example, if a patient with an 
Atrius Health PCP is seen by a Partners HealthCare specialist, 
the spending and utilization associated with the specialty 
visit is attributed to Atrius Health. Attributing patients in 
this manner is a commonly accepted method by providers 
and health plans and is utilized in most risk contracts. The 
process by which patients are attributed to provider organi-
zations is described in more detail in Sidebar: Methodology 
for PCP attribution and illustrated in Exhibit 4.1. For this 
analysis, the HPC examined only commercially insured adult 
patients, age 18 and older.
notes: Patients are matched with PCPs based on either explicit assignment as reported by their insurers to CHIA or by attribution 
methodologies similar to Medicare’s assignment of beneficiaries to Accountable Care Organizations.
eXHIbIT 4�1 Patient attribution methodology
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Methodology for PCP attribution
Patients were matched to primary care providers (PCPs) in a two-step hierarchical process using:
1.  assignment flags denoted by payers in the underlying claims data (primarily for enrollees of health 
maintenance organization (HMO) or point of service (POS) plans),
Or, for those lacking assignment flags:
2.  attribution algorithms that assign patients to PCPs empirically based on observed patterns of health 
care usage.i
Of the 1,942,273 adult patients with commercial coverage via either Blue Cross Blue Shield of Massa-
chusetts, Tufts Health plan, or Harvard Pilgrim Health Plan observed in the 2015 APCD, roughly 1.25 
million were assigned in the first step. The second step applied primarily to patients with preferred 
provider organization (PPO) coverage. Patients were assigned to the PCP who served the plurality of 
their Evaluation & Management (E&M) visits (routine doctor visits). The HPC used a limited set of visit 
codes for either well or sick-visits typically used in attribution algorithms (see Technical Appendix for 
details). For patients lacking any such visits, the HPC attributed a small number of additional patients 
to PCPs if they had at least three prescriptions filled by a single PCP. Overall, this second step resulted 
in the attribution of an additional 17 percent of adult patients in the APCD, or 48 percent of those not 
assigned in the first step. Ultimately, 1,583,976 out of a total of 1,942,273 (82 percent) adult patients in 
the database were attributed to a PCP using either method described above.
PCPs were associated with their parent organizations using the physician rosters available in data 
collected in the RPO Program. This data was supplemented with a commercial database obtained from 
SK&A, which has information on additional Massachusetts providers including nurse practitioners.
Of the 1,583,976 patients who matched to a PCP, 1,404,015 (89 percent) were matched to one of the 14 
largest provider organizations in Massachusetts. Of the 11 percent who were not matched to a pro-
vider organization, most had PCPs who could not be identified in the RPO or SK&A databases; a small 
remainder was matched to provider groups with fewer than 18,000 identifiable patients and was thus 
not separately identified in the analyses based on the smaller sample size. Finally, in the exhibits pre-
sented here, the patient population was limited further to exclude a small number of individuals with 
missing data on any of the patient characteristics used in the adjustments, resulting in a final sample 
of 1,355,527 adult patients.
i This method is conceptually similar to that used widely in literature and in the Medicare ACO programs.
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ATTRIBUTED PATIENT CHARACTERISTICS
In comparing provider organizations, it is important to note 
that their adult, commercially insured patient populations 
differ in some respects, noted in Exhibit 4.2.
For example, commercially insured adult patients attributed 
to Southcoast Health system had 9 percent greater health 
risk than patients of other systems, while those attributed 
to Boston Medical Center (BMC) physicians had 18 percent 
lower health risk on average, in part because they were 
considerably younger. Patients in Southcoast Health, who 
are typically from the New Bedford/Fall River region, lived 
in zip codes with the lowest average household income 
($61,679), similar to those in the Baystate and BMC sys-
tems, while those attributed to Mount Auburn Community 
Independent Practice Association (MACIPA) were from the 
highest-income areas among all provider groups ($89,359 
average income). The HPC also characterized areas where 
patients reside using the Area Deprivation Index,1 which 
measures additional socioeconomic factors such as home 




% over 55 % self  insured % female
number of 
patients
Atrius 0.93 $86,091 77.0 26% 50% 56% 174,927 
BMC 0.82 $65,518 88.5 19% 54% 53% 36,666 
Baystate 0.95 $62,560 99.1 31% 32% 52% 49,543 
BIDCO 1.00 $84,690 76.6 26% 43% 54% 145,143 
CMIPA 1.00 $70,164 95.9 27% 35% 51% 13,111 
Lahey 1.04 $88,455 77.8 31% 41% 52% 88,354 
MACIPA 0.97 $89,359 69.8 28% 44% 53% 32,141 
Partners 1.05 $88,340 76.8 29% 41% 55% 311,997 
Reliant 0.91 $80,265 89.9 24% 32% 52% 42,366 
South Shore 0.99 $85,507 82.5 27% 45% 56% 40,673 
Southcoast 1.09 $61,679 97.6 30% 48% 51% 17,916 
UMass 1.01 $74,609 93.7 30% 39% 52% 89,759 
Wellforce 1.02 $82,086 84.9 28% 42% 49% 129,378 
Steward 1.06 $71,796 90.3 30% 47% 52% 183,553 
notes: Green denotes a patient population with the lowest expected cost or utilization across provider groups as a result of the given charac-
teristic, while red denotes the highest. Columns without shading represent characteristics with inconsistent effects. Risk score was normalized 
to 1.0 across all adult patients in the sample. The area deprivation index combines a number of socio-economic-related measures by census 
block in the U.S. (including home values and amenities, employment, poverty, and education levels) measured at the 9-digit-zip code level. It 
is collapsed to 5 digits in this data. Values in Massachusetts range from 120 (greatest deprivation) in parts of Boston and Springfield to -12 
(least deprivation) in Weston. See sidebar: Methodology for PCP attribution for more details.
sources: HPC analysis of the Massachusetts All-Payer Claims Database, 2015; Registration of Provider Organizations, 2016; SK&A, 2015; U.S. 
Census Bureau, American Community Survey. University of Wisconsin-Madison HIPxChange, 2017
eXHIbIT 4�2 Descriptive statistics of commercially insured population attributed to a provider organization
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values, poverty and unemployment. Based on the index, Bay-
state’s patients reside in the most deprived areas of the state, 
while patients of MACIPA live in the least-deprived areas.
In order to provide reasonable comparisons across provider 
organizations, all of the findings reported here were adjusted 
for differences in patient populations: spending outcomes 
are adjusted for patient risk, while utilization outcomes are 
adjusted for all measures shown in Exhibit 4.2, in addition 
to the payer mix and percentage of patients in HMO or POS 
plans.
VARIATION IN SPENDING
Average risk-adjusted spending per member per year varied 
substantially across provider organizations (see Exhibit 4.3). 
The highest-cost organization spent 32 percent more per 
patient than the lowest-cost organization ($6,601 and $5,015, 
respectively), adjusting for patient risk. This difference in 
spending, more than $1,500 per patient per year, is substan-
tial and does not appear to be related to measures of quality.2 
The spending differences likely reflect a combination of 
factors including prices per service, intensity of services 
provided for a given condition, rates of utilization, practice 
ii The HPC grouped provider organizations based on the dominant hospital in the system, according to ownership and affiliation relationships as 
described in the RPO. Academic medical centers (AMCs) are a subcategory of teaching hospitals. Other hospital anchored provider organizations 
are those with systems anchored by either a teaching or community hospital.
patterns and culture, and patient factors not accounted for 
in risk adjustment.
For this analysis, the HPC further categorized provider orga-
nizations by organizational structure to investigate whether 
provider organizations owned by hospital systems tended 
to have higher spending than physician-led organizations.ii 
The findings showed that academic medical center (AMC)- 
anchored systems generally tend to have higher spending, 
and physician-led systems tend to have lower spending (see 
Exhibit 4.3). Comparing the composition of the systems, 
provider organizations anchored by an AMC were 13 percent 
more expensive than physician-led organizations ($6,176 ver-
sus $5,455), and 9 percent more than teaching or community 
hospital-based systems ($5,676). This pattern is consistent 
with recent research findings that hospital-based systems 
tend to be more expensive, potentially due to higher prices 
charged, higher utilization, or greater use of hospital-based 
sites, where physician-led systems tend to use lower-cost 
office-based settings for services that can be performed 
in either setting.3,4,5,6,7,8 For more information on variation 
in site of service, see Chapter 3: Hospital Outpatient 
Department Spending.
eXHIbIT 4�3 Average risk-adjusted commercial spending per member per year, by provider organization, 2015
notes: AMC = academic medical center. Spending adjusted using the Johns Hopkins Adjusted Clinical Groups (ACG®) grouper applied 
to claims data. Data includes only adults age 18 and older. Commercial payers include Blue Cross Blue Shield of Massachusetts, Harvard 
Pilgrim Health Care and Tufts Health Plan.
sources: HPC analysis of Massachusetts All Payer Claims Database, 2015; Registration of Provider Organizations, 2016; SK&A Office 
and Hospital Based Physicians Databases, December, 2015
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The HPC also examined spending variation by category of 
service to further understand drivers of spending differ-
ences across organizations. The greatest variation across 
provider groups occurred in the hospital outpatient spending 
category, where the highest-cost provider organization for 
hospital outpatient spending, Partners ($1,963), was twice 
as expensive as the lowest-cost provider, Reliant ($974) (see 
Exhibit 4.4). Generally, AMC-anchored provider organiza-
tions spent 66 percent more on hospital outpatient spending 
than physician-led organizations, which accounts for 96 
percent of the total difference in spending between these 
two types of systems.
Differences were smaller in other categories but still sub-
stantial. Inpatient spending varied 41 percent between the 
highest- and lowest-spending groups. Inpatient spend-
ing was on average 9 percent higher at AMC-anchored 
organizations than at physician-led organizations ($1,011 
versus $930). Pharmacy spending varied 38 percent between 
the highest- and lowest-spending group and followed similar 
patterns by type of organization. Laboratory and radiology 
spending (not shown) followed similar patterns as well. In 
contrast, professional spending was 9 percent higher in 
physician-led groups, suggesting that these groups may 
be substituting site-of-care for some services between phy-
sician offices and hospital outpatient departments, which 
are more expensive (see Chapter 3: Hospital Outpatient 
Department Spending). This difference is not enough to 
offset the more expensive outpatient spending, however. 
The HPC will continue monitoring differences in site of 
care to better understand underlying differences between 
outpatient and professional spending.
notes: AMC = academic medical center. Spending adjusted using the Johns Hopkins Adjusted Clinical 
Groups (ACG®) grouper applied to claims data. Data includes only adults age 18 and older. Commercial 
payers include Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care and Tufts Health Plan.
sources: HPC analysis of Massachusetts All-Payer Claims Database, 2015; Registration of Provider Orga-
nizations, 2016; SK&A Office and Hospital Based Physicians Databases, December, 2015
eXHIbIT 4�4 Average risk-adjusted commercial spending per member per year, 
by category of service and provider organization, 2015
HEALTH POLICY COMMISSION2017 COST TRENDS REPORT - 34 -
CHaPTeR 4: PRoVIDeR oRGanIZaTIon PeRfoRManCe VaRIaTIon  
UTILIZATION OF CARE
iii The avoidable hospital measure is based on criteria developed by the Agency for Healthcare Research and Quality’s Prevention Quality Indicators 
to identify ambulatory care sensitive conditions.
The HPC also analyzed health care utilization by provider 
organization. In 2015, the number of ED visits per 100 mem-
bers varied nearly two-fold across organizations (28.4 versus 
14.9, even after adjusting for demographic and health risk 
differences in patient characteristics (Exhibit 4.5).
These differences are substantial and may reflect a num-
ber of factors including patient preference and access to 
alternative sites of care, such as urgent care centers, retail 
clinics, after-hours care, telehealth, and primary care ser-
vices.9 AMC-anchored organizations had 26 percent more 
ED visits per 100 patients than physician-led organizations 
and 3 percent more ED visits than other hospital-anchored 
systems. The share of ED visits that were deemed avoidable 
also varied across organizations from 31 percent to 39 per-
cent, but was only weakly correlated with organization type.
The HPC also analyzed additional utilization measures, 
including rates of avoidable hospitalization.iii The number 
of hospital visits per 100 patients, also adjusted for the same 
array of demographic and health risk factors, varied by 24 
percent across organizations (from 4.0 to 4.9), while the per-
cent of such hospital visits that were avoidable varied more 
than two-fold, from 4.5 percent to 9.4 percent. Hospital visits 
did not vary significantly by organization type, consistent 
with findings in prior studies,6 although the HPC found 
that physician-led organizations had a lower percentage of 
hospital visits that were avoidable (4.9 percent compared to 
5.6 percent at hospital-anchored organizations).
In summary, AMC-and other hospital-anchored systems had 
generally higher spending per commercial patient, even after 
adjusting for health status. Their patients also went to the 
ED more often than did patients of physician-led provider 
organizations. The HPC has previously found that AMC- 
and other hospital-anchored systems tend to have lower 
shares of their patients covered under alternative payment 
methods, which could be related to the observed findings.10 
These contracts are designed to incentivize providers to 
reduce unnecessary spending, including by reducing ED 
notes: Avoidable ED visits are identified using the NYU Center for Health and Public Service Research Billings algorithm’s categorization 
of a patient’s primary diagnosis code. Avoidable visits include Billings categories of non-emergent and emergent, primary care treatable. 
Rates are adjusted for patient risk score, age, gender, income of patient zip code, area deprivation index of patient zip code, whether 
patient’s insurance plan is an HMO or POS plan, and whether patient’s firm is self or fully-insured.
sources: HPC analysis of Massachusetts All-Payer Claims Database, 2015; Registration of Provider Organizations, 2016; SK&A Office and 
Hospital Based Physicians Databases, December, 2015
eXHIbIT 4�5 Adjusted ED visits, per 100 members, by provider organization, 2015
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and hospital use and shifting care away from higher-cost 
settings. However, hospital-based systems may find that 
such strategies would work against maintaining hospital 
revenues and other financial interests.
Comparing provider organizations is complex, as the 
adjustments included may not account for all differences 
in underlying patient populations, and the methodology 
to aggregate provider organizations may not account for 
some structural characteristics that may influence results. 
Nevertheless, HPC research documents significant variation 
between provider organizations in Massachusetts on a range 
of performance metrics, including total patient spending, 
avoidable ED and hospital visits. Such variation, especially 
where correlated with certain organizational structures 
(e.g. AMC-anchored health systems), warrants additional 
scrutiny and analysis.
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PolICY ReCoMMenDaTIons
In light of the findings presented in this Report, as well as the 
HPC’s other research, policy, and program work throughout 
the year, the HPC has developed recommendations for mar-
ket participants, policymakers, and government agencies. 
These include neW recommendations for 2017, indicated 
in green, and renewed recommendations from previous 
years’ Cost Trends Reports, for which continued action, 
attention, and effort is required. The HPC has also updated 
its set of measures to track health system performance (see 
Dashboard, Exhibit 5.1).
In late 2017, the HPC restructured the policy committees 
of the HPC’s Board to better align with its priority policy 
outcomes and focus its work moving forward. The Board 
established two new committees, the Market Oversight 
and Transparency Committee (MOAT) and the Care 
Delivery Transformation Committee (CDT). Consistent 
with this strategic framework, the HPC recommends that 
the Commonwealth take action across the following two 
primary areas:
• Strengthening market functioning and transpar-
ency to promote a health care system in which payers 
and providers openly compete, providers are supported 
and equitably rewarded for providing high-quality and 
affordable services, and health system performance is 
transparent in order to implement reforms and evaluate 
performance over time.
• Promoting an efficient, high-quality system with 
aligned incentives that reduces spending and improves 
health by delivering coordinated, patient-centered, and 
efficient health care that accounts for patients’ behav-
ioral, social, and medical needs through the support of 




1 PHARMACEUTICAL SPENDING. The Common-wealth should take action to reduce increases in 
drug spending, and payers and providers should con-
sider further opportunities to maximize value. Payers 
and providers should increase emphasis on clinical and 
cost effectiveness of drugs, as well as increase scrutiny on 
prices, to support a more value-based market. Many other 
states are acting to moderate drug spending growth and 
enhance transparency, and Massachusetts should consider 
replicating promising approaches. Specific areas of focus 
should include:
a. Accountability and transparency: Building on action 
in other states, policymakers should increase transpar-
ency for pharmaceutical manufacturers in cases where 
a drug’s price increases or a new drug’s launch price 
may have a large impact on drug spending in the Com-
monwealth. In these cases, policymakers should require 
increased transparency in drug pricing and rebates as 
inputs to determine whether prices are excessive and 
unjustified. Increased transparency and accountability 
should apply to manufacturers and pharmacy benefit 
managers.
b. neW MassHealth Reforms: Policymakers should 
authorize the Executive Office of Health and Human 
Services to pursue new strategies for maximizing value 
in drug spending for the MassHealth program, including 
the enhanced ability to negotiate directly with drug man-
ufacturers for additional supplemental rebates, impose 
robust transparency requirements, and the ability to 
exclude certain drugs from the MassHealth formulary, 
similar to standard practice in commercial plans. Any 




3. Provider Price Variation
4. Facility Fees
5. Demand-Side Incentives
6. Social Determinants of Health
7. Health Care Workforce
8. Innovation Investments
9. Unnecessary Utilization
10. Alternative Payment Methods
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the basis of a rigorous review of evidence and demon-
stration of clinical effectiveness, and should include an 
exceptions process that allows for coverage of additional 
drugs when medically necessary. With these strategies, 
MassHealth will be better positioned to negotiate prices 
for covered drugs and promote market competition that 
can moderate drug prices and spending.
c. Witnesses for Cost Trends Hearing: Pharmaceutical 
and medical device manufacturers and pharmacy benefit 
managers are important market participants. Policymak-
ers should add representatives of these entities to the list 
of mandatory witnesses at the HPC’s annual Cost Trends 
Hearing.
d. Value-based contracting strategies: Payers should 
pursue the use of value-based benchmarks when nego-
tiating prices and consider opportunities for the use of 
risk-based contracting with manufacturers.
e. Treatment protocols and guidelines: Payers and pro-
viders should work together to develop and use treatment 
protocols and guidelines that make appropriate use of 
lower-cost drugs when available and to achieve consen-
sus on appropriate use when new high-cost drugs enter 
the market.
f. Prescriber education and variation in prescribing 
patterns: Providers should disseminate information to 
prescribers on drug and treatment alternatives, invest 
in system technology to alert prescribers to alternatives, 
support adoption of treatment protocols, and support 
other educational activities. Providers should also moni-
tor prescribing patterns, particularly for identification of 
outlier behavior, to help ensure that prescribing is con-
sistent with value-based and evidence-based guidelines.
2 OUT-OF-NETWORK BILLING. The Commonwealth should take action to enhance out-of-network pro-
tections for consumers. Consumers and insurers may face 
high charges from out-of-network hospitals and physicians 
in certain circumstances where consumers do not have 
the ability or information to select an in-network provider, 
including in emergency situations and when services are 
received at in-network facilities but provided by out-of-net-
work providers without the consumer’s informed agreement. 
These high out-of-network charges can create financial 
burdens for consumers and, when such costs are borne by 
insurers, they impair tiered and limited network products 
and increase overall spending. Drawing on models from 
other states (such as California, Connecticut, and New York), 
policy action should include:
a. Advance patient notice: Providers should be required to 
inform patients if they are out-of-network before services 
are delivered.
b. Consumer billing protections: Payers should be 
required to hold their members harmless in cases of out-
of-network emergency services and enhance consumer 
awareness of existing “surprise billing” protections.
c. Reasonable and fair reimbursement: Policymak-
ers, either by statute or through an appropriate state 
agency regulatory process, should establish a maximum 
reasonable price for such out-of-network services that 
will enhance the viability of limited and tiered network 
products, facilitate value-driven payer and provider rate 
negotiations, and ensure that out-of-network protections 
for consumers do not increase overall spending.
3 PROVIDER PRICE VARIATION. The Common-wealth should take action to reduce unwarranted 
variation in provider prices. Extensive variation in prices 
paid to health care providers for the same sets of services is 
a persistent issue in the Commonwealth, driving increased 
health care spending and perpetuating inequities in the 
distribution of health care resources. However, unwarranted 
variation in provider prices is not likely to decrease absent 
direct policy action. Policymakers should advance specific, 
data-driven interventions to address the pressing issue of 
persistent provider price variation in the coming year.
4 FACILITY FEES. The Commonwealth should take action to equalize payments for the same ser-
vices for similar patients between hospital outpatient 
departments and physician offices. In many cases, the 
same service can be provided at both hospital outpatient 
departments and physician offices, but hospital outpatient 
department rates and cost-sharing are substantially higher 
than those of physician offices for the same service due to 
the addition of hospital “facility fees.” The ability to charge 
these fees drives acquisition of physician groups by hospital 
systems which can result in higher prices paid for services. 
Policymakers and payers should act to limit both newly 
licensed and existing sites that can bill as hospital outpatient 
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departments and implement site neutral payments for select 
services for similar patients, both to reduce inappropriate 
health care spending and to reduce confusion for patients 
who can face increased cost sharing at hospital outpatient 
sites.
5 DEMAND-SIDE INCENTIVES. The Common-wealth should encourage payers and employers to 
enhance strategies that empower consumers to make 
high-value choices, including increasing the transpar-
ency of comparative prices and quality. Specific areas of 
focus should include:
a. Employee incentives for choosing high-value plans: 
Employers should further encourage selection of high-
value plans by contributing the same premium amount 
regardless of the plan chosen or by offering greater 
premium sharing for higher value plans. Additionally, 
employers should consider purchasing health insurance 
through the Massachusetts Health Connector, which 
provides consumers the opportunity to shop among a 
range of product options at competitive market rates.
b. Value-based provider choices: Employers should 
also explore options to encourage employees to make 
value-based provider choices, including by rewarding 
employees directly for choosing high-quality, efficient 
providers, or by directly establishing preferred provider 
contracts.
c. Tiered and limited insurance plans: Payers should con-
tinue to improve value-oriented products such as tiered 
and limited plan designs that create incentives, such as 
financial rewards, for choosing high-value services.
d. PCP tiering: Payers should tier PCPs on the basis of 
provider group TME. Payers should also increase the 
cost-sharing differentials between preferred and non-pre-
ferred tiers to better reflect value-based differences 
among providers.
e. Transparent price and quality information: Payers 
should increase the availability of information on price 
and quality at the point of referral to allow patients 
and providers to enhance the selection of value-based 
providers and make better-informed decisions about 
treatment options. Payers and purchasers should also 
take advantage of price and quality information available 
via CHIA’s new CompareCare website to empower and 
reward employees for choosing high-value care. Consis-
tent with the Commonwealth’s goal to be a national leader 
in health care data transparency, CHIA should continue 
efforts to make detailed health care price information 
easily available to the public.
PROMOTING AN EFFICIENT, HIGH-
QUalITY, HealTH CaRe DelIVeRY 
sYsTeM
6 neW SOCIAL DETERMINANTS OF HEALTH. The Commonwealth should continue to emphasize 
the impact of social determinants of health on health 
care access, outcomes, and costs. Emerging evidence 
demonstrates that addressing health-related social needs 
(e.g., housing, nutrition) improves health outcomes, reduces 
health disparities, and lowers avoidable health care utiliza-
tion. Policymakers and market participants should advance 
efforts to address social determinants of health, building on 
the leadership of the Executive Office of Health and Human 
Services through MassHealth’s Delivery System Reform 
Incentive Program (DSRIP) and other initiatives, specifically 
with a focus on:
a. Payment for health-related social needs: MassHealth 
plans to offer flexible services funding to DSRIP-partici-
pating ACOs to address health-related social needs (e.g., 
through housing supports or medically-appropriate 
meals) that are not otherwise reimbursed by MassHealth 
or other publicly-funded programs. Other payers should 
replicate and expand such payment innovations to pro-
vide flexible funding to medical providers to address a 
range of health-related social needs for patients, includ-
ing under global budget models.
b. Inclusion of social determinants of health in payment 
policies and performance measurement: Provider 
payment policies and performance measurement that 
do not account for social determinants of health can 
disadvantage providers and payers that serve high- need 
populations. Risk adjustment methodologies and per-
formance metrics should account for socio-economic 
and environmental factors where possible, and payers 
and providers should seek to expand collection of data 
necessary to understand the socio-demographics of the 
populations they serve (e.g., data on race, language, edu-
cation level, and income).
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c. Research and dissemination: Government agencies, 
researchers, providers, and payers should continue to 
pilot and evaluate innovative interventions, strategies, 
and policies that address health-related social needs. 
Research and evaluation of programs that demonstrate 
improvements in health and reductions in unnecessary 
health care spending should be widely disseminated.
7 neW HEALTH CARE WORKFORCE. The Com-monwealth should support advancements in the 
health care workforce that promote top-of-license prac-
tice and new care teams models. In order to enhance 
the successful implementation of new care delivery and 
payment reform initiatives, the Commonwealth should 
engage frontline health care workers in health care cost 
containment efforts and continue to support workforce 
innovations, such as multi-disciplinary care teams that 
include new types of roles and professions. Additionally, in 
order to improve access to high-quality care, policymakers 
should ensure that all providers can efficiently and effec-
tively deliver care without restriction, consistent with their 
license and training. Specific areas of focus should include:
a. Scope of practice: Policymakers should review and 
amend scope of practice laws that are restrictive and 
not evidence-based, including for Advanced Practice 
Registered Nurses. Policymakers should also certify a 
new level of dental practitioner to increase access to oral 
health care, particularly for low income and underserved 
populations.
b. New care team models: The Commonwealth should con-
tinue to support the increased adoption of new care team 
models, in which roles are designed to meet the unique 
needs of the communities and patient populations they 
serve (e.g., community health workers, patient naviga-
tors, peer support specialists, and recovery coaches). 
Early evidence from the HPC’s CHART program indicates 
that employing these types of workers on the care team, 
particularly to address patients’ behavioral health and 
health-related social needs, helps reduce unnecessary 
hospital utilization and improve outcomes. Specifically, 
policymakers should consider establishing streamlined 
credentialing processes for these roles aligned with other 
states’ and national standards, supporting additional 
training and educational opportunities, and endorsing 
payment policies that enable such services to be provided.
8 neW INNOVATION INVESTMENTS. The Com-monwealth should continue to invest in testing, 
evaluating, and scaling innovative care delivery models. 
Early evidence from the HPC’s CHART and HCII programs 
indicates that investments in innovative care models can 
successfully improve outcomes, reduce unnecessary utiliza-
tion, and strengthen community-based care. Policymakers, 
payers, providers, and other market participants should con-
tinue to support targeted investments, including for models 
that enhance behavioral health care access and treatment. 
Examples of emerging ideas that should be considered for 
funding include:
a. Pharmacologic treatment in primary care: Expansion 
of access to pharmacologic treatment in the primary 
care setting is critical to stemming the tide of the opioid 
epidemic in the Commonwealth, reducing avoidable 
acute care utilization, and improving outcomes. Payers 
should reduce or eliminate cost sharing for patients to 
increase access to and engagement in pharmacologic 
treatment for opioid use disorder.
b. Telehealth: The state, payers, and providers should 
partner to develop, test, and leverage the expertise of the 
Massachusetts-based digital health innovation commu-
nity to scale the use of telehealth in the Commonwealth, 
particularly to enhance access to care for certain high-
need services and patient populations. Behavioral health 
and teledentistry are especially important areas of focus. 
Further, the Commonwealth should examine and address 
policy and payment barriers to increased use of tele-
health, including under global budget models.
c. Mobile integrated health: The state, payers, providers, 
and local communities should collaborate to implement 
models of mobile integrated health, in which community 
paramedicine and other providers treat patients in their 
homes and communities and appropriately avoid acute 
care utilization.
9 UNNECESSARY UTILIZATION. The Common-wealth should focus on reducing unnecessary 
utilization and increasing the provision of care in high-
value, low-cost settings. Unnecessary utilization and the 
provision of care in higher cost settings (e.g., low-acuity ED 
visits, BH-related ED visits, readmissions, use of teaching 
hospitals and academic medical centers for communi-
ty-appropriate inpatient care, institutional post-acute care) 
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continue to be significant drivers of health care spending. 
Payers and providers should be accountable for making 
progress on the HPC’s improvement targets as detailed in 
the health system performance dashboard found in Exhibits 
5.1 and 5.2, and for shifting care, as appropriate, to high-
value, low-cost settings.
10 ALTERNATIVE PAYMENT METHODS. The Commonwealth should continue to promote 
the increased adoption of alternative payment methods 
(APMs) and improvements in APM effectiveness. Payers 
and providers have not made sufficient progress to meet the 
HPC targets as detailed in the system performance dash-
board found in Exhibits 5.1 and 5.2. While APM coverage 
is likely to increase in 2018 due to the implementation of 
the MassHealth ACO program, considerable opportunities 
remain in the commercial market for payers and providers 
to increase APM adoption for self-insured and PPO popu-
lations. Payers should also align and improve features of 
APMs in order increase their effectiveness. Specific areas 
of focus should include:
a. neW Quality measurement: Payers should imple-
ment the consensus quality measure set in global budget 
APMs as developed by the Executive Office of Health 
and Human Services’ Quality Alignment Taskforce. The 
consensus measure set represents a vision for multi-
payer alignment of quality measurement for ACOs that 
seeks to promote measurement of outcomes and reduce 
administrative burden for payers and providers.
b. HPC ACO Certification: Payers and purchasers should 
require that provider organizations participating in APM 
contracts obtain the HPC’s ACO Certification to ensure 
common care delivery competencies across provider 
networks.
c. Bundled payments: As a complement to global payment 
and a core strategy to reduce unnecessary post-acute 
care utilization, payers and providers should expand 
implementation of bundled payments for common and 
costly episodes of care such as joint replacement, cardiac 
care, cancer treatment, and maternity.
d. Disparities in budget levels: As part of a strategy to 
reduce spending, payers should develop plans to lessen 
the unwarranted disparities in global budgets paid to 
different providers such as by establishing stricter tar-
gets for spending growth for highly paid providers and 
by moving away from historical spending as the basis of 
global budgets.
ConClUsIon
In the coming year, the HPC will pursue the activities 
noted above and work collaboratively with the Baker-Polito 
Administration, state Legislature, Massachusetts health care 
industry, employers, consumers, and other stakeholders to 
advance the goals of a more affordable, effective, account-
able, and transparent health care system in Massachusetts.
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TY 1 Individuals with high out-of-pocket spending relative to income 11% (2014-2015) 11% (2015-2016) 14% (2015-2016)














3 Percentage of beneficiaries in Original Medicare cov-ered by APMs 39.5% (2015) 36.9% (2016) 19.9% (2016)
4 Percentage of commercial HMO patients in APMs 58.2% (2015) 58.6% (2016) N/A N/A
5 Percentage of commercial PPO patients in APMs 1.1% (2015) 14.7% (2016) N/A N/A
6 Percentage of MassHealth members in APMs (PCC) 23% (2015) 24% (2016) N/A N/A












8 Growth of THCE per capita (performance assessed relative to 3.6% benchmark) 4.8% (2015) 2.8% (2016) 3.5% (2016)
9 Growth in commercial health insurance premiums 1.8% (2015) 2.6% (2016) 5.2% (2016)
10 Employer-based health insurance premiums, single coverage $6,519 (2015) $6,621 (2016) $6,101 (2016)
11 Growth in employer-based health insurance premiums, single coverage 2.7% (2015) 1.6% (2016) 2.3% (2016)
12 Benchmark premium for second-lowest-cost ex-change plan, single coverage $3,084 (2015) $2,976 (2016) $4,332 (2016)























14 Readmission rate (Medicare) 17.9% (2014) 18.2% (2015) 16.8% (2015)
15 Readmission rate (All payer) 15.3% (2014) 15.8% (2015) N/A N/A
16 ED utilization (per 1,000 persons) 365 (2015) 368 (2016) N/A N/A
17 BH-related ED utilization (per 1,000 persons) 27 (2015) 29 (2016) N/A N/A
18 Low-acuity avoidable ED Utilization 40 (2015) 38 (2016) N/A N/A
19 Percentage of inpatient discharges to institutional PAC 19.3% (2015) 18.7% (2016) MA = 20.4%  U.S. = 17.1% (2014)













21 Enrollment in tiered or limited network products 18.4% (2015) 19.4% (2016) N/A N/A
22 Percentage of discharges in top 5 networks 59.9% (2015) 60.5% (2016) N/A N/A




eXHIbIT 5�1 Dashboard of HPC system performance metrics
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eXHIbIT 5�2 Dashboard of HPC improvement targets
Better performance
Projected to meet target
Similar performance
Worse performance
Projected to not meet  
target
Metric Current HPC Target Performance
Growth of total health care expenditures per capita 2.8% (2016) 3.6% (2016)
All-payer readmission rate (the rate at which patients 
who have been discharged are readmitted again within 
30 days for all payers)
15.8% (2015) 13.0% (2019)
Percentage of commercial HMO patients in Alternative 
Payment Methods 58.6% (2016) 80.0% (2017)
Percentage of commercial PPO patients in Alternative 
Payment Methods 14.7% (2016) 33.0% (2017)
Percentage of inpatient discharges to institutional PAC 20.4% (2014) 17.1% (2020)
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notes: THCE = total health care expenditures; ED = emergency depart-
ment; PAC = post-acute care; HMO = health maintenance organization; 
PPO = preferred provider organization; APM = alternative payment 
method. For additional notes, see Technical Appendix.
sources:
Measure 1: Hayes SL, et al. What’s at Stake: States’ Progress on 
Health Coverage and Access to Care, 2013–2016. The Com-
monwealth Fund. 2017 December. Available from: http://www.
commonwealthfund.org/publications/issue-briefs/2017/dec/
states-progress-health-coverage-and-access.
Measure 2: Agency for Healthcare Research and Quality. 2016 Medi-
cal Expenditure Panel Survey, Insurance Component. Available from: 
https://meps.ahrq.gov/survey_comp/Insurance.jsp.






Measure 4: Center for Health Information and Analysis. Annual Report 
on the Performance of the Massachusetts Health Care System: 2017 
Annual Report APM Databook. 2017 September. Available from: http://
www.chiamass.gov/annual-report/.
Measure 5: Center for Health Information and Analysis. Annual Report 
on the Performance of the Massachusetts Health Care System: 2017 
Annual Report APM Databook. 2017 September. Available from: http://
www.chiamass.gov/annual-report/.
Measure 6: Center for Health Information and Analysis. Annual Report 
on the Performance of the Massachusetts Health Care System. 2017 
September. Available from: http://www.chiamass.gov/annual-report/.
Measure 7: Center for Health Information and Analysis. Annual Report 
on the Performance of the Massachusetts Health Care System. 2017 
September. Available from: http://www.chiamass.gov/annual-report/.
Measure 8: MA - Center for Health Information and Analysis. Annual 
Report on the Performance of the Massachusetts Health Care 
System, Total Health Care Expenditures Databook. 2017 Sep-
tember. Available from: http://www.chiamass.gov/annual-report/; 
US - Centers for Medicare and Medicaid Services National Health 
Expenditure Data. 2017. Available from: https://www.cms.gov/
research-statistics-data-and-systems/statistics-trends-and-reports/
nationalhealthexpenddata/.
Measure 9: MA - Center for Health Information and Analysis. Annual 
Report on the Performance of the Massachusetts Health Care 
System, Private Commercial Contract Enrollment, Coverage Costs, 
Cost-Sharing, Payer Use of Funds Technical Appendix. 2017 Sep-
tember. Available from: http://www.chiamass.gov/annual-report/; 
US - Centers for Medicare and Medicaid Services National Health 
Expenditure Data. 2017. Available from: https://www.cms.gov/
research-statistics-data-and-systems/statistics-trends-and-reports/
nationalhealthexpenddata/.
Measure 10: Agency for Healthcare Research and Quality. 2016 Med-
ical Expenditure Panel Survey, Insurance Component. Available from: 
https://meps.ahrq.gov/survey_comp/Insurance.jsp.
Measure 11: Agency for Healthcare Research and Quality. 2016 Med-
ical Expenditure Panel Survey, Insurance Component. Available from: 
https://meps.ahrq.gov/survey_comp/Insurance.jsp.
Measure 12: Kaiser Family Foundation. State Health Facts, Health 
Reform, Health Insurance Marketplaces, Marketplace Average Bench-
mark Premiums. Available from: https://www.kff.org/health-reform/
state-indicator/marketplace-average-benchmark-premiums/.
Measure 13: Kaiser Family Foundation. State Health Facts, Health 
Reform, Health Insurance Marketplaces, Marketplace Average Bench-
mark Premiums. Available from: https://www.kff.org/health-reform/
state-indicator/marketplace-average-benchmark-premiums/.
Measure 14: Centers for Medicare and Medicaid Services. Geo-
graphic Variation Public Use File: State Table— Beneficiaries 65 
And Older. 2017 Apr 11. Available from: https://www.cms.gov/
Research-Statistics-Data-and-Systems/Statistics-Trends-and-Re-
ports/Medicare-Geographic-Variation/GV_PUF.html.
Measure 15: Center for Health Information and Analysis. Hos-
pital-Wide Adult All-Payer Readmissions In Massachusetts: 
SFY 2011-2015. 2016 Dec. Available from: http://www.chiamass.
gov/hospital-wide-adult-all-payer-readmissions-in-massachu-
setts-sfy-2011-2015/.
Measure 16: Center for Health Information and Analysis. Emergency 
Department Database, 2017. Available from: http://www.chiamass.
gov/case-mix-data.
Measure 17: Center for Health Information and Analysis. Emergency 
Department Database, 2017. Available from: http://www.chiamass.
gov/case-mix-data.
Measure 18: Center for Health Information and Analysis. Emergency 
Department Database, 2017. Available from: http://www.chiamass.
gov/case-mix-data.
Measure 19: MA - Center for Health Information and Analysis. Hos-
pital Inpatient Discharge Database, 2017. Available from: http://www.
chiamass.gov/case-mix-data; US - Agency for Healthcare Research 
and Quality. Health Healthcare Cost and Utilization Project (HCUP), 
Nationwide Inpatient Sample Survey. 2016 Nov. Available from: https://
www.hcup-us.ahrq.gov/.
Measure 20: Hayes SL, et al. What’s at Stake: States’ Progress 
on Health Coverage and Access to Care, 2013–2016. The Com-
monwealth Fund. 2017 December. Available from: http://www.
commonwealthfund.org/publications/issue-briefs/2017/dec/
states-progress-health-coverage-and-access.
Measure 21: Center for Health Information and Analysis. Annual Report 
on the Performance of the Massachusetts Health Care System, Private 
Commercial Contract Enrollment, Coverage Costs, Cost-Sharing, 
Payer Use of Funds Technical Appendix. 2017 September. Available 
from: http://www.chiamass.gov/annual-report/.
Measure 22: Center for Health Information and Analysis. Hospital 
Inpatient Discharge Database, 2017. Available from: http://www.chi-
amass.gov/case-mix-data.
Measure 23: Center for Health Information and Analysis. Hospital 
Inpatient Discharge Database, 2017. Available from: http://www.chi-
amass.gov/case-mix-data.
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